Maven Capital — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Carcinotech produces bioprinted tumor models combining patient-derived biological material with automated workflows to generate reproducible tumor tissue systems for drug discovery and testing.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesEdinburgh, GB
Lorna(Chief Scientific Officer)
Co-investorsAlba EquityTRICAPITALBritish Business BankEos AdvisoryGabriel Investment SyndicateInvesting Women Angels+3 more
XSwap is a cross-chain DeFi platform for swaps, bridging, token creation and payments built on Chainlink CCIP.
Co-investorsWWVenturesCogitent VenturesMH VenturesPragma VenturesZBS CAPITAL
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.